Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
Status:
Withdrawn
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether the use of polyethylene glycol is superior
and more safe in treating hepatic encephalopathy compared to lactulose and also to determine
if treatment with polyethylene glycol will reduce the duration of hospital stay.
Phase:
N/A
Details
Lead Sponsor:
New York Methodist Hospital New York Presbyterian Brooklyn Methodist Hospital